Quiroga, Dionisia
Lyerly, H. Kim
Morse, Michael A.
Funding for this research was provided by:
Conquer Cancer Foundation of the American Society of Clinical Oncology
Article History
First Online: 17 June 2016
Compliance with Ethical Standards
:
: Dionisia Quiroga declares that she has no conflict of interest.H. Kim Lyerly declares that he has no conflict of interest.Michael A. Morse will be participating as a clinical investigator in the Keynote-177 trial sponsored by Merck Sharp & Dohme Corporation (NCT02563002), but will not be receiving any direct financial compensation. He has also received financial support through grants from Bristol-Myers Squibb, Merck, Aduro Biotech, AlphaVax, and Advaxis, and has received compensation from EMD Serono for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by either of the authors.